Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-30), Vimab Group AB's 14-Day RSI is 61.23.
The industry rank for Vimab Group AB's 14-Day RSI or its related term are showing as below:
OSTO:VIMAB's 14-Day RSI is ranked worse than 78.15% of 1126
companies
in the Business Services industry
Industry Median: 49.295
vs OSTO:VIMAB: 61.23
Vimab Group AB (OSTO:VIMAB) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Vimab Group AB 14-Day RSI Related Terms
OSTO:VIMAB vs VRSK, EFX, BAH: 14-Day RSI Comparison
For the Consulting Services subindustry, Vimab Group AB's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vimab Group AB 14-Day RSI vs Business Services Industry
For the Business Services industry and Industrials sector, Vimab Group AB's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Vimab Group AB's 14-Day RSI falls into.
Vimab Group AB (OSTO:VIMAB) 14-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vimab Group AB (OSTO:VIMAB) has a 14-Day RSI of 61.23 as of Jul. 30, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Vimab Group AB and its competitors. According to the industry distribution chart, Vimab Group AB ranks #880 out of 1126 companies in the Business Services industry, placing it in the top 78.2%.
Is Vimab Group AB's 14-Day RSI too high?
Vimab Group AB's current 14-Day RSI is 61.23. The Business Services industry median 14-Day RSI is 49.30. Vimab Group AB's value of 61.23 is 24.2% above this industry median. Based on the distribution chart, Vimab Group AB ranks #880 out of 1126 companies in the Business Services industry, which is in the bottom quartile relative to peers. Overall, Vimab Group AB has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vimab Group AB's 14-Day RSI compare to VRSK and EFX?
According to the Business Services industry distribution chart, Vimab Group AB ranks #880 out of 1126 companies for 14-Day RSI. This places Vimab Group AB in the lower half of its industry. The industry median 14-Day RSI is 49.30. Vimab Group AB's value of 61.23 is 24.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Business Services company?
The median 14-Day RSI among Business Services companies is 49.30, based on 1,126 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vimab Group AB's current 14-Day RSI of 61.23 is 24.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Vimab Group AB and its competitors. For the Business Services industry, the median 14-Day RSI is 49.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vimab Group AB's current 14-Day RSI is 61.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimab Group AB stock overvalued right now?
Based on GuruFocus' analysis, Vimab Group AB (OSTO:VIMAB) is currently considered Possible Value Trap. The stock's GF Value™ is kr5.96, compared to a current price of kr3.22 — trading 46% below its estimated fair value. The current 14-Day RSI is 61.23 and 24.2% above the Business Services industry median of 49.30. Vimab Group AB's overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Vimab Group AB (OSTO:VIMAB), the current 14-Day RSI is 61.23 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vimab Group AB (OSTO:VIMAB) Overvalued in 2026?
Based on GuruFocus' analysis, Vimab Group AB stock appears to be undervalued.
The current stock price of kr3.22 is trading 46% below its estimated GF Value™ of kr5.96.
GuruFocus considers Vimab Group AB to be Possible Value Trap.
Key valuation signals for OSTO:VIMAB:
14-Day RSI: 61.23
GF Value™: kr5.96 vs. price of kr3.22 (46% below fair value)
Industry Position: 24.2% above the Business Services median (#880 of 1126)
No single metric tells the full story. See the OSTO:VIMAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.
51GF Score
Get the complete analysis for OSTO:VIMAB
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:VIMAB has been successfully added to your 
